Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06223633 · ClinicalTrials.gov registry record · NA
PK(Pharmacokinetic) Papyrus Covered Coronary Stent System
A NA study, sponsored by Methodist Health System.
- Recruiting
- Registry status
- NA
- Development phase
- 41
- Enrollment target
NCT06223633 is a NA study that is actively recruiting participants, run by Methodist Health System. The registered enrollment target is 41 participants.
The verdict
NCT06223633, a NA study, is actively recruiting participants, sponsored by Methodist Health System.
- RECRUITING
- Registry status
- NA
- Development phase
- 41 participants
- Enrollment target
Study Summary
The PK Papyrus Covered Coronary Stent System is a coronary stent being used at Methodist Dallas Medical Center for patients with coronary perforations.
Interventions
- DEVICE PK Papyrus Covered Coronary Stent System
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 41 participants |
| Start Date | 2023-08-10 |
| Est. Completion | 2028-08 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06223633
The ClinicalTrials.gov registry entry for NCT06223633 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 41 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Methodist Health System, which has 125 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which PK Papyrus Covered Coronary Stent System is the first listed.
NCT06223633 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06223633 about?
NCT06223633 is a clinical study titled "PK(Pharmacokinetic) Papyrus Covered Coronary Stent System". The PK Papyrus Covered Coronary Stent System is a coronary stent being used at Methodist Dallas Medical Center for patients with coronary perforations.
What is the current status of trial NCT06223633?
This trial is currently recruiting. It is a NA study. The enrollment target is 41 participants. The study started on 2023-08-10. Estimated completion is 2028-08.
What interventions are being tested in trial NCT06223633?
The interventions under investigation include: PK Papyrus Covered Coronary Stent System (DEVICE).
Who is sponsoring clinical trial NCT06223633?
This trial is sponsored by Methodist Health System, which has 125 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.